Breaking News

Lilly to End Production at Guayama, PR Plant

Two other PR sites will support insulin and biologics portfolio

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Eli Lilly and Co. is pursuing the sale of one of its three manufacturing plants in PR. The Guayama site will remain in operation until the end of 2015. The approximately 100 full-time employees will be offered employment at Lilly’s Carolina, PR location.   Lilly began manufacturing operations in PR in 1965 and has approximately 1,600 employees there. The company expects to record a charge of approximately $170 million in 4Q14.   “The decision to conclude operations at Guayama is base...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters